Partner Headlines - ECTE

  1. Mid-Day Market Update: Wednesday's Movers, China Intervenes With ...

    Benzinga
  2. Morning Market Losers

    Benzinga
  3. Echo Therapeutics Mails Letter to Shareholders; Urges Not to ...

    Benzinga
  4. Echo Therapeutics Comments on Proxy Contest by Platinum Management ...

    Benzinga
  5. Platinum Management (NY) LLC Urges Stockholders to Take No Action ...

    Benzinga
  6. Echo Therapeutics Submits CE Mark Technical File to European ...

    Benzinga
  7. Morning Market Losers

    Benzinga
  8. Morning Market Movers

    Benzinga
  9. Echo Therapeutics Schedules Meeting with Platinum-Montaur Next ...

    Benzinga
  10. Echo Therapeutics Announces CEO, President and Chairman, Dr. ...

    Benzinga
  11. LifeTech Capital Reiterates Neutral Rating on Echo Therapeutics ...

    Benzinga
  12. Echo Therapeutics Prices 13.33M Share Offering @ $0.75/Share

    Benzinga
  13. Echo Therapeutics to Report Trial Results of Symphony tCGM System ...

    Benzinga
  14. Echo Therapeutics Prices 3.2M Share Offering @$0.95/Share

    Benzinga
  15. Stocks Hitting 52-Week Lows

    Benzinga
  16. Stocks Hitting 52-Week Lows

    Benzinga
  17. Echo Therapeutics Announces Proposed Public Offering

    Benzinga
  18. Echo Therapeutics Announces $20 Million Financing with Platinum-Montaur ...

    Benzinga
  19. Benzinga's Top Initiations

    Benzinga
  20. Echo Therapeutics Announces Positive Clinical Trial Results of ...

    Benzinga
  21. UPDATE: Wunderlich Securities Initiates Coverage of Echo Therapeutics ...

    Benzinga
  22. Echo Therapeutics Expands License Agreement with Ferndale Pharma

    Benzinga
  23. Echo Therapeutics Presents Positive Clinical Trial Results of ...

    Benzinga
  24. Benzinga's Top Downgrades With Color for May 14, 2012

    Benzinga
  25. Echo Therapeutics Announces Positive Clinical Trial Results of ...

    Benzinga
  26. Echo Therapeutics Initiates Clinical Trials of its Symphony tCGM ...

    Benzinga
  27. LifeTech Has Strong Speculative Buy, $6 PT On Echo Therapeutics

    Benzinga
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!